DIFFERENCES IN CARDIAC CALCIUM RELEASE CHANNEL (RYANODINE RECEPTOR) EXPRESSION IN MYOCARDIUM FROM PATIENTS WITH END-STAGE HEART-FAILURE CAUSED BY ISCHEMIC VERSUS DILATED CARDIOMYOPATHY

被引:170
|
作者
BRILLANTES, AM
ALLEN, P
TAKAHASHI, T
IZUMO, S
MARKS, AR
机构
[1] CUNY MT SINAI SCH MED,BROOKDALE CTR MOLEC BIOL,DIV MOLEC MED,BOX 1126,NEW YORK,NY 10029
[2] CUNY MT SINAI SCH MED,DEPT MED,DIV CARDIOL,NEW YORK,NY 10029
[3] BRIGHAM & WOMENS HOSP,DEPT ANESTHESIOL,BOSTON,MA 02115
[4] HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,MOLEC MED UNIT,BOSTON,MA 02215
[5] HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,DIV CARDIOVASC,BOSTON,MA 02215
关键词
IDIOPATHIC DILATED CARDIOMYOPATHY; ISCHEMIC CARDIOMYOPATHY; CALCIUM RELEASE CHANNEL; MESSENGER RNA; RYANODINE RECEPTOR;
D O I
10.1161/01.RES.71.1.18
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The molecular basis for the systolic and diastolic dysfunction characteristic of end-stage heart failure in humans remains poorly understood. It has been proposed that both abnormal calcium handling and defects in the contractile apparatus may contribute to the myocardial dysfunction. Two channels, the calcium release channel (CRC) or ryanodine receptor of the sarcoplasmic reticulum (SR), and the slow calcium channel or dihydropyridine receptor (DHPR) of the transverse tubule, play key roles in regulating intracellular calcium concentration and in excitation-contraction (E-C) coupling in the heart. The DHPR serves as the voltage sensor and plasma membrane calcium channel resulting in activation of the CRC during E-C coupling in heart muscle. In this study, we investigated the levels of CRC expression in several forms of end-stage heart failure in humans. A cardiac CRC cDNA was cloned from rabbit and used as a probe for Northern blot analyses to determine mRNA levels in the left ventricles of normal (n=4) and cardiomyopathic (n=34) human hearts from patients undergoing cardiac transplantation. Compared with normal patients, patients with ischemic cardiomyopathy (n=18) showed a 28% decrease in CRC mRNA levels (p<0.025) and patients with idiopathic dilated cardiomyopathy (n=14) a nonsignificant 12% increase. In these same hearts, alpha-actin levels were unchanged in end-stage heart failure, as has been previously reported. This is the first report indicating that the expression of the CRC mRNA is abnormal in end-stage human heart failure. The decreased expression of the CRC found specifically in patients with ischemic myopathy (but not idiopathic dilated cardiomyopathy) may, in part, explain differences in calcium handling and response to therapy observed among patients with different forms of cardiomyopathy. Decreased CRC expression could be related to abnormal contractile function in cardiomyopathic muscle resulting from ischemic insult.
引用
收藏
页码:18 / 26
页数:9
相关论文
共 50 条
  • [1] Sarcoplasmic reticulum dysfunction in myocardium from patients with end-stage heart failure caused by ischemic vs idiopathic dilated cardiomyopathy
    Sen, LY
    Cui, GG
    Xu, DC
    Fonarow, GC
    Laks, H
    CIRCULATION, 1996, 94 (08) : 2535 - 2535
  • [2] ABNORMAL INTRACELLULAR CALCIUM HANDLING IN MYOCARDIUM FROM PATIENTS WITH END-STAGE HEART-FAILURE
    GWATHMEY, JK
    COPELAS, L
    MACKINNON, R
    SCHOEN, FJ
    FELDMAN, MD
    GROSSMAN, W
    MORGAN, JP
    CIRCULATION RESEARCH, 1987, 61 (01) : 70 - 76
  • [3] EXPRESSION OF DIHYDROPYRIDINE RECEPTOR (CA-2+ CHANNEL) AND CALSEQUESTRIN GENES IN THE MYOCARDIUM OF PATIENTS WITH END-STAGE HEART-FAILURE
    TAKAHASHI, T
    ALLEN, PD
    LACRO, RV
    MARKS, AR
    DENNIS, AR
    SCHOEN, FJ
    GROSSMAN, W
    MARSH, JD
    IZUMO, S
    JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (03): : 927 - 935
  • [4] REGIONAL EXPRESSION OF THE CALCIUM-RELEASE CHANNEL (RYANODINE RECEPTOR) IN HUMAN HEART-FAILURE
    GO, LO
    MARX, SO
    FYFE, BS
    MARKS, AR
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, : A464 - A464
  • [5] The apelinergic system cardiac expression in patients with idiopathic or ischemic end-stage dilated cardiomyopathy
    Cabiati, M.
    Svezia, B.
    Botta, L.
    Matteucci, M.
    Lionetti, V.
    Del Ry, S.
    CLINICA CHIMICA ACTA, 2019, 493 : S185 - S186
  • [6] BETA-BLOCKADE WITH BUCINDOLOL IN HEART-FAILURE CAUSED BY ISCHEMIC VERSUS IDIOPATHIC DILATED CARDIOMYOPATHY
    WOODLEY, SL
    GILBERT, EM
    ANDERSON, JL
    OCONNELL, JB
    DEITCHMAN, D
    YANOWITZ, FG
    MEALEY, PC
    VOLKMAN, K
    RENLUND, DG
    MENLOVE, R
    BRISTOW, MR
    CIRCULATION, 1991, 84 (06) : 2426 - 2441
  • [7] DECREASED INOTROPIC EFFECT OF PHOSPHODIESTERASE INHIBITORS IN MYOCARDIUM FROM PATIENTS WITH END-STAGE HEART-FAILURE
    FELDMAN, M
    GWATHMEY, J
    COPELAS, L
    SCHOEN, F
    MORGAN, JP
    CIRCULATION, 1985, 72 (04) : 404 - 404
  • [8] REVERSAL OF THE FORCE-FREQUENCY RELATIONSHIP IN WORKING MYOCARDIUM FROM PATIENTS WITH END-STAGE HEART-FAILURE
    FELDMAN, MD
    GWATHMEY, JK
    PHILLIPS, P
    SCHOEN, F
    MORGAN, JP
    JOURNAL OF APPLIED CARDIOLOGY, 1988, 3 (04) : 273 - 283
  • [9] Familial Dilated Cardiomyopathy (FDCM) Prevalence in End-Stage Non-Ischemic Heart Failure (ESHF)
    Jacoby, D. L.
    DePasquale, E. C.
    Lour, O.
    Pomianowski, P.
    McKenna, W. J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S52 - S52
  • [10] The cardiac ryanodine receptor (calcium release channel): Emerging role in heart failure and arrhythmia pathogenesis
    Scoote, M
    Williams, AJ
    CARDIOVASCULAR RESEARCH, 2002, 56 (03) : 359 - 372